Instituto Dor de Pesquisa E Ensino Sp

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Liver and biliary tract cancer

Running trials

• Active, not recruiting

  Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation

  NCT06501625· Phase 1/2· Institut de Recherches Internationales Servier· Source